Form 4 for EXEL EXELIXIS, INC.
Accepted 2024-12-02 00:00:00 ET · period of report 2024-11-27 · accession 0000939767-24-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-02 | 2024-11-27 | EXEL | Hessekiel Jeffrey | EVP, GC | F - Tax | $35.93 | -98.9K | 546.1K | -15% | -$3.55M |
| D | 2024-12-02 | 2024-11-29 | EXEL | Hessekiel Jeffrey | EVP, GC | S - Sale+OE | $36.67 | -60.0K | 486.1K | -11% | -$2.20M |
| D | 2024-12-02 | 2024-11-29 | EXEL | Hessekiel Jeffrey | EVP, GC | G - Gift | $0.00 | -15.0K | 471.1K | -3% | $0 |
| D | 2024-12-02 | 2024-11-27 | EXEL | Hessekiel Jeffrey | EVP, GC | M - OptEx | $18.80 | +129.3K | 645.0K | +25% | +$2.43M |
| D | 2024-12-02 | 2024-11-27 | EXEL | Hessekiel Jeffrey | EVP, GC | M - OptEx | $0.00 | -129.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-27 | F | D | 98,908 | $35.93 | 546,059 | D | — | — | (F2) Represents a "net exercise" of an outstanding stock option to purchase 129,314 shares, and pursuant to which the Reporting Person received 30,406 shares, of Common Stock. The Issuer withheld 98,908 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on November 27, 2024 of $35.93. (F1) Includes 207,072 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. |
| 2 | Common | Common Stock | 2024-11-29 | S | D | 60,000 | $36.67 | 486,059 | D | — | — | (F3) Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.36 to $36.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. (F1) Includes 207,072 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. |
| 3 | Common | Common Stock | 2024-11-29 | G | D | 15,000 | $0.00 | 471,059 | D | — | — | (F1) Includes 207,072 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. |
| 4 | Common | Common Stock | 2024-11-27 | M | A | 129,314 | $18.80 | 644,967 | D | — | — | (F1) Includes 207,072 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. |
| 5 | Derivative | Option (right to buy) | 2024-11-27 | M | D | 129,314 | $0.00 | 0 | D | $18.80 · 2019-09-10 to 2025-09-09 | 129,314 Common Stock | (F6) The option, representing the right to purchase a total of 129,314 shares of Common Stock, became fully exercisable on September 10, 2022. |